前往化源商城

Medical Oncology 2015-05-01

Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines.

Yan Zhang, Xueyan Zhang, Jinsu Huang, Qianggang Dong

文献索引:Med. Oncol. 32(5) , 157, (2015)

全文:HTML全文

摘要

The refractory pulmonary adenocarcinoma is characterized by its metastasis and resistance to cytotoxic agents. While the underlying molecular mechanism is unclear, the property of chemoresistance may mainly lie in the presence of highly resistant cancer stem cells. We examined the function of Wnt/β-catenin signaling in maintaining cancer stem cells (CSCs) in lung adenocarcinoma. Lentivirus-mediated knockdown of β-catenin expression accelerated cell cycle. Subsequently, β-catenin knockdown PC9 cells improve the sensitivity to chemotherapy. Further focusing on Wnt signal by administrating PP and EGFR-TKIs as Wnt antagonists can decrease metastasis and induce apoptosis. Collectively, these results indicate that Wnt signaling pathway plays an essential role in maintaining highly resistant CSCs, regulation of cell cycle, metastasis and apoptosis in lung adenocarcinoma.

相关化合物

结构式 名称/CAS号 全部文献
5-(((2,5-二氧吡咯烷-1-基)氧基)羰基)-3-羰基-3H-螺-[异苯并呋喃-1,9'-氧杂蒽]-3',6'-二基 二乙酸酯 结构式 5-(((2,5-二氧吡咯烷-1-基)氧基)羰基)-3-羰基-3H-螺-[异苯并呋喃-1,9'-氧杂蒽]-3',6'-二基 二乙酸酯
CAS:150206-05-6
4-羟乙基哌嗪乙磺酸 结构式 4-羟乙基哌嗪乙磺酸
CAS:7365-45-9
四硫富瓦烯 结构式 四硫富瓦烯
CAS:31366-25-3
5(6)-羧基二乙酸荧光素琥珀酰亚胺酯(CFDA) 结构式 5(6)-羧基二乙酸荧光素琥珀酰亚胺酯(CFDA)
CAS:150347-59-4